In light of claims of improved efficacy and lower incidence of adverse effects compared with older drugs, second-generation antipsychotics have emerged as the predominant treatment for schizophrenia.

The use of antipsychotic drugs to treat conditions not approved by the Food and Drug Administration has increased significantly in the last decade in children and adults. Conditions include ...

Although the exact mechanism of SGAs for MDD has not yet been ... [92] 120 patients were randomized to ziprasidone monotherapy (drug–drug) for 12 weeks, placebo for 6 weeks followed by ...

In addition to antipsychotics, other medications used include lithium, thyroid hormone, low doses of stimulants, anticonvulsants, and other classes of antidepressants, such as tricyclic ...